The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Supernus Pharmaceuticals, Inc(NASDAQ:SUPN) 
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the t...
Website: http://www.supernus.com
Founded: 2005
Full Time Employees: 464
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Supernus Pharmaceuticals Days Payable Outstanding ttm (DPO)
Supernus Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Supernus Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Supernus Pharmaceuticals Op Cashflow Per Share ttm
Supernus Pharmaceuticals Free Cashflow Per Share ttm
Supernus Pharmaceuticals Cash Per Share ttm
Supernus Pharmaceuticals P/S ratio ttm
Supernus Pharmaceuticals (GAAP) P/E ratio ttm
Supernus Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.